RIL
TMCI icon

Rothschild Investment LLC’s Treace Medical Concepts TMCI Stock Holding History

Rothschild Investment LLC’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09K Buy
275
+231
+525% +$635 ﹤0.01% 3012
2026
Q1 		$59 Buy
+44
New +$88 ﹤0.01% 3446
2025
Q4 		– Sell
-195
Closed -$1.31K – 3496
2025
Q3 		$1.31K Buy
195
+50
+34% +$326 ﹤0.01% 2474
2025
Q2 		$853 Sell
145
-55
-28% -$358 ﹤0.01% 2549
2025
Q1 		$1.68K Buy
200
+55
+38% +$494 ﹤0.01% 2008
2024
Q4 		$1.08K Buy
145
+105
+263% +$703 ﹤0.01% 2169
2024
Q3 		$232 Buy
40
+20
+100% +$128 ﹤0.01% 2684
2024
Q2 		$133 Buy
20
+10
+100% +$81 ﹤0.01% 2621
2024
Q1 		$131 Buy
+10
New +$133 ﹤0.01% 2028

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Rothschild Investment LLC's TMCI Position: Q2 2026 in Review

Rothschild Investment LLC increased its Treace Medical Concepts (TMCI) stake by 525% in Q2 2026, buying an estimated $635 and bringing the position to 275 shares worth $1.09K. The position accounts for ﹤0.01% of the portfolio, ranked #3012.

Rothschild Investment LLC first reported a position in TMCI in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.68K in Q1 2025. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Rothschild Investment LLC held 275 shares of Treace Medical Concepts worth $1.09K as of Q2 2026.
  • Rothschild Investment LLC bought 231 Treace Medical Concepts shares in Q2 2026, an estimated $635.
  • Treace Medical Concepts made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3012 holding.
  • Rothschild Investment LLC first reported a position in Treace Medical Concepts in Q1 2024 and has held it in 9 quarters since.
  • Rothschild Investment LLC's Treace Medical Concepts position peaked at $1.68K in Q1 2025.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.